Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection

Alzheimer’s disease (AD) is a common neurodegenerative disorder. The number of patients with AD is projected to reach 152 million by 2050. Donepezil, rivastigmine, galantamine, and memantine are the only four drugs currently approved by the United States Food and Drug Administration for AD treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiaranaikulwanitch, Jutamas, Pandith, Hataichanok, Tadtong, Sarin, Thammarat, Phanit, Jiranusornkul, Supat, Chauthong, Nattapong, Nilkosol, Supitcha, Vajragupta, Opa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999550/
https://www.ncbi.nlm.nih.gov/pubmed/33809092
http://dx.doi.org/10.3390/molecules26061562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999550/
https://www.ncbi.nlm.nih.gov/pubmed/33809092
http://dx.doi.org/10.3390/molecules26061562

Ejemplares similares